human lung fibroblast cell line atcc ccl 95 1 Search Results


av 951  (Selleck Chemicals)
93
Selleck Chemicals av 951
Av 951, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lung+fibroblast+cell+line+atcc+ccl+95+1/us12351822-1024-20-23?v=Selleck+Chemicals
Average 93 stars, based on 1 article reviews
av 951 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier
wi 26 va4  (ATCC)
95
ATCC wi 26 va4
TGFBR1 (transforming growth factor-β receptor type 1) was upregulated by TFAP2C (transcription factor-activating enhancer-binding protein 2C) in non-small-cell lung cancer (NSCLC) cells. ( a ) The effects of TFAP2C knockdown by treatment of TFAP2C small interfering RNA (siRNA) (#1 and #2) on the expression of TGFBR1 mRNA and protein in NCI-H292 and NCI-H838 cells were analyzed by real-time quantitative RT-PCR (qRT-PCR) and western blotting, respectively. Based on these results, TFAP2C siRNA no 1 was used for the subsequent experiments. ( b ) The effects of TFAP2C upregulation on the expression of TGFBR1 mRNA and protein in MRC5 and WI-26 <t>VA4</t> cells were analyzed by real-time qRT-PCR and western blotting, respectively. * P <0.05 compared with control cells. Error bars represent±s.e.m. ( n =3); Student's t -test.
Wi 26 Va4, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lung+fibroblast+cell+line+atcc+ccl+95+1/pmc05133372-42-17-23?v=ATCC
Average 95 stars, based on 1 article reviews
wi 26 va4 - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier
nsclc a 549 atcc  (ATCC)
90
ATCC nsclc a 549 atcc
TGFBR1 (transforming growth factor-β receptor type 1) was upregulated by TFAP2C (transcription factor-activating enhancer-binding protein 2C) in non-small-cell lung cancer (NSCLC) cells. ( a ) The effects of TFAP2C knockdown by treatment of TFAP2C small interfering RNA (siRNA) (#1 and #2) on the expression of TGFBR1 mRNA and protein in NCI-H292 and NCI-H838 cells were analyzed by real-time quantitative RT-PCR (qRT-PCR) and western blotting, respectively. Based on these results, TFAP2C siRNA no 1 was used for the subsequent experiments. ( b ) The effects of TFAP2C upregulation on the expression of TGFBR1 mRNA and protein in MRC5 and WI-26 <t>VA4</t> cells were analyzed by real-time qRT-PCR and western blotting, respectively. * P <0.05 compared with control cells. Error bars represent±s.e.m. ( n =3); Student's t -test.
Nsclc A 549 Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lung+fibroblast+cell+line+atcc+ccl+95+1/pmc06332147__molecules___20___12029___s001-41-168-169?v=ATCC
Average 90 stars, based on 1 article reviews
nsclc a 549 atcc - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
mouse anti psd 95  (NeuroMab)
96
NeuroMab mouse anti psd 95
TGFBR1 (transforming growth factor-β receptor type 1) was upregulated by TFAP2C (transcription factor-activating enhancer-binding protein 2C) in non-small-cell lung cancer (NSCLC) cells. ( a ) The effects of TFAP2C knockdown by treatment of TFAP2C small interfering RNA (siRNA) (#1 and #2) on the expression of TGFBR1 mRNA and protein in NCI-H292 and NCI-H838 cells were analyzed by real-time quantitative RT-PCR (qRT-PCR) and western blotting, respectively. Based on these results, TFAP2C siRNA no 1 was used for the subsequent experiments. ( b ) The effects of TFAP2C upregulation on the expression of TGFBR1 mRNA and protein in MRC5 and WI-26 <t>VA4</t> cells were analyzed by real-time qRT-PCR and western blotting, respectively. * P <0.05 compared with control cells. Error bars represent±s.e.m. ( n =3); Student's t -test.
Mouse Anti Psd 95, supplied by NeuroMab, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lung+fibroblast+cell+line+atcc+ccl+95+1/pmc04332023-56-54-57?v=NeuroMab
Average 96 stars, based on 1 article reviews
mouse anti psd 95 - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier
mhc i  (Developmental Studies Hybridoma Bank)
95
Developmental Studies Hybridoma Bank mhc i
TGFBR1 (transforming growth factor-β receptor type 1) was upregulated by TFAP2C (transcription factor-activating enhancer-binding protein 2C) in non-small-cell lung cancer (NSCLC) cells. ( a ) The effects of TFAP2C knockdown by treatment of TFAP2C small interfering RNA (siRNA) (#1 and #2) on the expression of TGFBR1 mRNA and protein in NCI-H292 and NCI-H838 cells were analyzed by real-time quantitative RT-PCR (qRT-PCR) and western blotting, respectively. Based on these results, TFAP2C siRNA no 1 was used for the subsequent experiments. ( b ) The effects of TFAP2C upregulation on the expression of TGFBR1 mRNA and protein in MRC5 and WI-26 <t>VA4</t> cells were analyzed by real-time qRT-PCR and western blotting, respectively. * P <0.05 compared with control cells. Error bars represent±s.e.m. ( n =3); Student's t -test.
Mhc I, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lung+fibroblast+cell+line+atcc+ccl+95+1/pm19106243-102-5-9?v=Developmental+Studies+Hybridoma+Bank
Average 95 stars, based on 1 article reviews
mhc i - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier
laminin  (Developmental Studies Hybridoma Bank)
99
Developmental Studies Hybridoma Bank laminin
TGFBR1 (transforming growth factor-β receptor type 1) was upregulated by TFAP2C (transcription factor-activating enhancer-binding protein 2C) in non-small-cell lung cancer (NSCLC) cells. ( a ) The effects of TFAP2C knockdown by treatment of TFAP2C small interfering RNA (siRNA) (#1 and #2) on the expression of TGFBR1 mRNA and protein in NCI-H292 and NCI-H838 cells were analyzed by real-time quantitative RT-PCR (qRT-PCR) and western blotting, respectively. Based on these results, TFAP2C siRNA no 1 was used for the subsequent experiments. ( b ) The effects of TFAP2C upregulation on the expression of TGFBR1 mRNA and protein in MRC5 and WI-26 <t>VA4</t> cells were analyzed by real-time qRT-PCR and western blotting, respectively. * P <0.05 compared with control cells. Error bars represent±s.e.m. ( n =3); Student's t -test.
Laminin, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lung+fibroblast+cell+line+atcc+ccl+95+1/pmc03101036-75-44-18?v=Developmental+Studies+Hybridoma+Bank
Average 99 stars, based on 1 article reviews
laminin - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier
cd19 car detection  (Miltenyi Biotec)
95
Miltenyi Biotec cd19 car detection
TGFBR1 (transforming growth factor-β receptor type 1) was upregulated by TFAP2C (transcription factor-activating enhancer-binding protein 2C) in non-small-cell lung cancer (NSCLC) cells. ( a ) The effects of TFAP2C knockdown by treatment of TFAP2C small interfering RNA (siRNA) (#1 and #2) on the expression of TGFBR1 mRNA and protein in NCI-H292 and NCI-H838 cells were analyzed by real-time quantitative RT-PCR (qRT-PCR) and western blotting, respectively. Based on these results, TFAP2C siRNA no 1 was used for the subsequent experiments. ( b ) The effects of TFAP2C upregulation on the expression of TGFBR1 mRNA and protein in MRC5 and WI-26 <t>VA4</t> cells were analyzed by real-time qRT-PCR and western blotting, respectively. * P <0.05 compared with control cells. Error bars represent±s.e.m. ( n =3); Student's t -test.
Cd19 Car Detection, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lung+fibroblast+cell+line+atcc+ccl+95+1/pmc09935551__BLOOD_BLD___2021___015020___mmc1-19-49-51?v=Miltenyi+Biotec
Average 95 stars, based on 1 article reviews
cd19 car detection - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier
cd24  (Miltenyi Biotec)
93
Miltenyi Biotec cd24
TGFBR1 (transforming growth factor-β receptor type 1) was upregulated by TFAP2C (transcription factor-activating enhancer-binding protein 2C) in non-small-cell lung cancer (NSCLC) cells. ( a ) The effects of TFAP2C knockdown by treatment of TFAP2C small interfering RNA (siRNA) (#1 and #2) on the expression of TGFBR1 mRNA and protein in NCI-H292 and NCI-H838 cells were analyzed by real-time quantitative RT-PCR (qRT-PCR) and western blotting, respectively. Based on these results, TFAP2C siRNA no 1 was used for the subsequent experiments. ( b ) The effects of TFAP2C upregulation on the expression of TGFBR1 mRNA and protein in MRC5 and WI-26 <t>VA4</t> cells were analyzed by real-time qRT-PCR and western blotting, respectively. * P <0.05 compared with control cells. Error bars represent±s.e.m. ( n =3); Student's t -test.
Cd24, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lung+fibroblast+cell+line+atcc+ccl+95+1/10__1161_slash_hypertensionaha__120__16218-33-20-22?v=Miltenyi+Biotec
Average 93 stars, based on 1 article reviews
cd24 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier
130 095 951 cd326  (Miltenyi Biotec)
96
Miltenyi Biotec 130 095 951 cd326
TGFBR1 (transforming growth factor-β receptor type 1) was upregulated by TFAP2C (transcription factor-activating enhancer-binding protein 2C) in non-small-cell lung cancer (NSCLC) cells. ( a ) The effects of TFAP2C knockdown by treatment of TFAP2C small interfering RNA (siRNA) (#1 and #2) on the expression of TGFBR1 mRNA and protein in NCI-H292 and NCI-H838 cells were analyzed by real-time quantitative RT-PCR (qRT-PCR) and western blotting, respectively. Based on these results, TFAP2C siRNA no 1 was used for the subsequent experiments. ( b ) The effects of TFAP2C upregulation on the expression of TGFBR1 mRNA and protein in MRC5 and WI-26 <t>VA4</t> cells were analyzed by real-time qRT-PCR and western blotting, respectively. * P <0.05 compared with control cells. Error bars represent±s.e.m. ( n =3); Student's t -test.
130 095 951 Cd326, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lung+fibroblast+cell+line+atcc+ccl+95+1/pmc08383762-30-6-15?v=Miltenyi+Biotec
Average 96 stars, based on 1 article reviews
130 095 951 cd326 - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier
primary antibodies  (R&D Systems)
92
R&D Systems primary antibodies
TGFBR1 (transforming growth factor-β receptor type 1) was upregulated by TFAP2C (transcription factor-activating enhancer-binding protein 2C) in non-small-cell lung cancer (NSCLC) cells. ( a ) The effects of TFAP2C knockdown by treatment of TFAP2C small interfering RNA (siRNA) (#1 and #2) on the expression of TGFBR1 mRNA and protein in NCI-H292 and NCI-H838 cells were analyzed by real-time quantitative RT-PCR (qRT-PCR) and western blotting, respectively. Based on these results, TFAP2C siRNA no 1 was used for the subsequent experiments. ( b ) The effects of TFAP2C upregulation on the expression of TGFBR1 mRNA and protein in MRC5 and WI-26 <t>VA4</t> cells were analyzed by real-time qRT-PCR and western blotting, respectively. * P <0.05 compared with control cells. Error bars represent±s.e.m. ( n =3); Student's t -test.
Primary Antibodies, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lung+fibroblast+cell+line+atcc+ccl+95+1/pmc08423435-369-0-18?v=R%26D+Systems
Average 92 stars, based on 1 article reviews
primary antibodies - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier
vegfr inhibitor av 951  (Selleck Chemicals)
94
Selleck Chemicals vegfr inhibitor av 951
TGFBR1 (transforming growth factor-β receptor type 1) was upregulated by TFAP2C (transcription factor-activating enhancer-binding protein 2C) in non-small-cell lung cancer (NSCLC) cells. ( a ) The effects of TFAP2C knockdown by treatment of TFAP2C small interfering RNA (siRNA) (#1 and #2) on the expression of TGFBR1 mRNA and protein in NCI-H292 and NCI-H838 cells were analyzed by real-time quantitative RT-PCR (qRT-PCR) and western blotting, respectively. Based on these results, TFAP2C siRNA no 1 was used for the subsequent experiments. ( b ) The effects of TFAP2C upregulation on the expression of TGFBR1 mRNA and protein in MRC5 and WI-26 <t>VA4</t> cells were analyzed by real-time qRT-PCR and western blotting, respectively. * P <0.05 compared with control cells. Error bars represent±s.e.m. ( n =3); Student's t -test.
Vegfr Inhibitor Av 951, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lung+fibroblast+cell+line+atcc+ccl+95+1/pm28916756-308-1-4?v=Selleck+Chemicals
Average 94 stars, based on 1 article reviews
vegfr inhibitor av 951 - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier
jasco hplc instrument  (JASCO Inc)
97
JASCO Inc jasco hplc instrument
TGFBR1 (transforming growth factor-β receptor type 1) was upregulated by TFAP2C (transcription factor-activating enhancer-binding protein 2C) in non-small-cell lung cancer (NSCLC) cells. ( a ) The effects of TFAP2C knockdown by treatment of TFAP2C small interfering RNA (siRNA) (#1 and #2) on the expression of TGFBR1 mRNA and protein in NCI-H292 and NCI-H838 cells were analyzed by real-time quantitative RT-PCR (qRT-PCR) and western blotting, respectively. Based on these results, TFAP2C siRNA no 1 was used for the subsequent experiments. ( b ) The effects of TFAP2C upregulation on the expression of TGFBR1 mRNA and protein in MRC5 and WI-26 <t>VA4</t> cells were analyzed by real-time qRT-PCR and western blotting, respectively. * P <0.05 compared with control cells. Error bars represent±s.e.m. ( n =3); Student's t -test.
Jasco Hplc Instrument, supplied by JASCO Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lung+fibroblast+cell+line+atcc+ccl+95+1/pm39647867-39-10-10?v=JASCO+Inc
Average 97 stars, based on 1 article reviews
jasco hplc instrument - by Bioz Stars, 2026-07
97/100 stars
  Buy from Supplier

Image Search Results


TGFBR1 (transforming growth factor-β receptor type 1) was upregulated by TFAP2C (transcription factor-activating enhancer-binding protein 2C) in non-small-cell lung cancer (NSCLC) cells. ( a ) The effects of TFAP2C knockdown by treatment of TFAP2C small interfering RNA (siRNA) (#1 and #2) on the expression of TGFBR1 mRNA and protein in NCI-H292 and NCI-H838 cells were analyzed by real-time quantitative RT-PCR (qRT-PCR) and western blotting, respectively. Based on these results, TFAP2C siRNA no 1 was used for the subsequent experiments. ( b ) The effects of TFAP2C upregulation on the expression of TGFBR1 mRNA and protein in MRC5 and WI-26 VA4 cells were analyzed by real-time qRT-PCR and western blotting, respectively. * P <0.05 compared with control cells. Error bars represent±s.e.m. ( n =3); Student's t -test.

Journal: Experimental & Molecular Medicine

Article Title: TFAP2C-mediated upregulation of TGFBR1 promotes lung tumorigenesis and epithelial–mesenchymal transition

doi: 10.1038/emm.2016.125

Figure Lengend Snippet: TGFBR1 (transforming growth factor-β receptor type 1) was upregulated by TFAP2C (transcription factor-activating enhancer-binding protein 2C) in non-small-cell lung cancer (NSCLC) cells. ( a ) The effects of TFAP2C knockdown by treatment of TFAP2C small interfering RNA (siRNA) (#1 and #2) on the expression of TGFBR1 mRNA and protein in NCI-H292 and NCI-H838 cells were analyzed by real-time quantitative RT-PCR (qRT-PCR) and western blotting, respectively. Based on these results, TFAP2C siRNA no 1 was used for the subsequent experiments. ( b ) The effects of TFAP2C upregulation on the expression of TGFBR1 mRNA and protein in MRC5 and WI-26 VA4 cells were analyzed by real-time qRT-PCR and western blotting, respectively. * P <0.05 compared with control cells. Error bars represent±s.e.m. ( n =3); Student's t -test.

Article Snippet: The human NSCLC cell lines, NCI-H292 and NCI-H838, and the human normal lung cell lines, MRC5 and WI-26 VA4, were acquired from the American Type Culture Collection (ATCC, Manassas, VA, USA), authenticated and maintained in early passages, no more than 6 months after receipt from ATCC.

Techniques: Binding Assay, Knockdown, Small Interfering RNA, Expressing, Quantitative RT-PCR, Western Blot, Control